NeoGenomics, Inc. (NEO) financial statements and ratios from SEC XBRL: revenue $0.7B (TTM), net margin -14.9%, revenue growth 11.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $727.33M |
| Revenue (TTM) | $0.7B |
| Net Margin | -14.9% |
| Return on Equity | -12.0% |
| Operating Margin (TTM) | -14.2% |
| Debt / Equity | 0.41 |
| Current Ratio | 4.42 |
| Net Debt / EBITDA | -2.8 |
| Interest Coverage | -38.9 |
| Revenue Growth (YoY) | 11.1% |
| FCF Growth (YoY) | -56.0% |
| Altman Z-Score | 2.65 (grey) |
| Piotroski F-Score | 5/9 |
| Piotroski checks passed | 5 of 9 |
| Industry P/E (Business Services) | 28.3 |
| Sector P/E (Technology) | 31.8 |
NEO overview · NEO earnings · NEO KPIs · NEO documents · NEO ownership · NEO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.